Boston Scientific Corporation (BSX) is a developer, manufacturer and marketer of medical devices that are used in a broad range of interventional medical specialties. The Healthcare sector has certainly been full of mergers, acquisitions and potential inversions. Boston Scientific has earned a SELL WATCH classification with the recent rapid move to the upside reaching 140.3% FV. This places the company at 480 out of 500 stocks in the S&P500 Index. The stock became overvalued when it passed through $20.31 and moved up to $21.92. There may remain more movement to the upside, but the probability is getting lower as it moves further upward.
Boston Scientific Corporation (BSX) – Moves to “Sell/Watch” classification
About the Author: Steve Albrecht
Steven Albrecht was the President and CEO of Charter Trust Company from 2001-2016